Demographic and clinical characteristics of pediatric patients treated for ALL at Texas Children’s Hospital, 2007 to 2018
| Variable . | Total (N = 314) . | Sample . | P value . | |
|---|---|---|---|---|
| Discovery (N = 234) . | Replication (N = 80) . | |||
| Age at diagnosis, y | .93 | |||
| Median (range) | 5.0 (1.0-19) | 5.0 (1.0-19) | 5.5 (1.0-17) | |
| BMI category | .65 | |||
| Normal weight | 184 (58.6%) | 137 (58.5%) | 47 (58.8%) | |
| Obese | 38 (12.1%) | 27 (11.5%) | 11 (13.8%) | |
| Overweight | 38 (12.1%) | 30 (12.8%) | 8 (10.0%) | |
| Underweight | 32 (10.2%) | 25 (10.7%) | 7 (8.8%) | |
| Missing | 22 (7.0%) | 15 (6.4%) | 7 (8.8%) | |
| Sex | .99 | |||
| Female | 138 (43.9%) | 103 (44.0%) | 35 (43.8%) | |
| Male | 176 (56.1%) | 131 (56.0%) | 45 (56.3%) | |
| Race/ethnicity | .43 | |||
| Hispanic | 181 (57.6%) | 135 (57.7%) | 46 (57.5%) | |
| Non-Hispanic Black | 15 (4.8%) | 12 (5.1%) | 3 (3.8%) | |
| Non-Hispanic Other | 15 (4.8%) | 11 (4.7%) | 4 (5.0%) | |
| Non-Hispanic White | 100 (31.8%) | 75 (32.1%) | 25 (31.3%) | |
| Missing | 3 (1.0%) | 1 (0.4%) | 2 (2.5%) | |
| Risk group | .06 | |||
| High-risk/T cell | 134 (42.7%) | 94 (40.2%) | 40 (50.0%) | |
| Standard risk | 180 (57.3%) | 140 (59.8%) | 40 (50.0%) | |
| ALL subtype | .30 | |||
| B cell | 294 (93.6%) | 221 (94.4%) | 73 (91.3%) | |
| T cell | 20 (6.4%) | 13 (5.6%) | 7 (8.8%) | |
| Transaminitis (AST or ALT) | .02 | |||
| Grade <3 | 193 (61.5%) | 132 (56.4%) | 61 (76.3%) | |
| Grade ≥3 | 88 (28.0%) | 69 (29.5%) | 19 (23.8%) | |
| Missing | 33 (10.5%) | 33 (14.1%) | 0 (0%) | |
| Conjugated hyperbilirubinemia | .20 | |||
| ≤3 mg/dL | 305 (97.1%) | 225 (96.2%) | 80 (100%) | |
| >3 mg/dL | 7 (2.2%) | 7 (3.0%) | 0 (0%) | |
| Missing | 2 (0.6%) | 2 (0.9%) | 0 (0%) | |
| Variable . | Total (N = 314) . | Sample . | P value . | |
|---|---|---|---|---|
| Discovery (N = 234) . | Replication (N = 80) . | |||
| Age at diagnosis, y | .93 | |||
| Median (range) | 5.0 (1.0-19) | 5.0 (1.0-19) | 5.5 (1.0-17) | |
| BMI category | .65 | |||
| Normal weight | 184 (58.6%) | 137 (58.5%) | 47 (58.8%) | |
| Obese | 38 (12.1%) | 27 (11.5%) | 11 (13.8%) | |
| Overweight | 38 (12.1%) | 30 (12.8%) | 8 (10.0%) | |
| Underweight | 32 (10.2%) | 25 (10.7%) | 7 (8.8%) | |
| Missing | 22 (7.0%) | 15 (6.4%) | 7 (8.8%) | |
| Sex | .99 | |||
| Female | 138 (43.9%) | 103 (44.0%) | 35 (43.8%) | |
| Male | 176 (56.1%) | 131 (56.0%) | 45 (56.3%) | |
| Race/ethnicity | .43 | |||
| Hispanic | 181 (57.6%) | 135 (57.7%) | 46 (57.5%) | |
| Non-Hispanic Black | 15 (4.8%) | 12 (5.1%) | 3 (3.8%) | |
| Non-Hispanic Other | 15 (4.8%) | 11 (4.7%) | 4 (5.0%) | |
| Non-Hispanic White | 100 (31.8%) | 75 (32.1%) | 25 (31.3%) | |
| Missing | 3 (1.0%) | 1 (0.4%) | 2 (2.5%) | |
| Risk group | .06 | |||
| High-risk/T cell | 134 (42.7%) | 94 (40.2%) | 40 (50.0%) | |
| Standard risk | 180 (57.3%) | 140 (59.8%) | 40 (50.0%) | |
| ALL subtype | .30 | |||
| B cell | 294 (93.6%) | 221 (94.4%) | 73 (91.3%) | |
| T cell | 20 (6.4%) | 13 (5.6%) | 7 (8.8%) | |
| Transaminitis (AST or ALT) | .02 | |||
| Grade <3 | 193 (61.5%) | 132 (56.4%) | 61 (76.3%) | |
| Grade ≥3 | 88 (28.0%) | 69 (29.5%) | 19 (23.8%) | |
| Missing | 33 (10.5%) | 33 (14.1%) | 0 (0%) | |
| Conjugated hyperbilirubinemia | .20 | |||
| ≤3 mg/dL | 305 (97.1%) | 225 (96.2%) | 80 (100%) | |
| >3 mg/dL | 7 (2.2%) | 7 (3.0%) | 0 (0%) | |
| Missing | 2 (0.6%) | 2 (0.9%) | 0 (0%) | |